{
  "id": 9554924,
  "title": "Bristol Myers Squibb and Johnson & Johnson Both Face Challenges Ahead: Which Healthcare Stock Looks More Resilient Now?",
  "url": "https://urgent.news/2026/09/24/bristol-myers-squibb-and-johnson-johnson-both-face-challenges-ahead-9554924",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-24T11:56:01.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/bristol-myers-squibb-and-johnson-johnson-both-face-challenges-ahead-which-healthcare-stock"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsBristol Myers Squibb maintains a robust specialized drug portfolio and generates strong free cash flow to support its operations.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}